Business Context and Reporting Period
This Form 8-K is a current report filed by Anthem, Inc. (now Elevance Health, Inc.) on September 17, 2015. The filing serves as a Regulation FD disclosure regarding upcoming communications with securities analysts and investors scheduled between September 17, 2015, and September 30, 2015.
Key Financial Metrics
The filing does not provide historical revenue, profit, cash flow, margin, debt, or liquidity figures for the current or prior periods. It focuses exclusively on forward-looking guidance for the full year 2015.
- Full Year 2015 Net Income Guidance: Greater than $9.55 per share.
- Unfavorable Adjustment Items: Included in the above guidance are greater than $0.45 per share of net unfavorable adjustments.
- Adjusted Net Income Guidance: Excluding the unfavorable items, the company expects adjusted net income to be greater than $10.00 per share.
Material Changes and Outlook
Management reaffirmed its full-year 2015 net income guidance during the reporting period. The guidance explicitly excludes any adjustments beyond those reported in the Company's second quarter 2015 earnings release. No material changes to prior period financial results are detailed in this specific document.
Risks, Contingencies, and Unusual Items
The filing includes a comprehensive Safe Harbor statement identifying significant risks that could cause actual results to differ from projections. Key risks include:
- Pending Acquisition: Uncertainties regarding the acquisition of Cigna Corporation, including regulatory approvals, shareholder votes, integration challenges, and the realization of synergies.
- Regulatory Environment: Impacts of the Patient Protection and Affordable Care Act, health care cost trends, and premium rate adequacy in Individual and Small Group markets.
- Cybersecurity: Ongoing risks related to the cyber attack reported in February 2015, including potential litigation and data breaches.
- Operational Risks: Provider contracting, Medicare/Medicaid compliance, financial strength rating downgrades, and information system modernization.
Investor Verification Checklist
- Verify the status of regulatory approvals and shareholder votes for the Cigna Corporation acquisition.
- Review the Q2 2015 earnings release to understand the specific nature of the $0.45 per share unfavorable adjustment items.
- Monitor updates regarding the February 2015 cyber attack and associated litigation or financial penalties.
- Assess the impact of Health Care Reform on premium rates and enrollment in Individual and Small Group markets.